Raymond F. Suckow - Concepedia

Author

Raymond F. Suckow

Also Known As

R F Suckow, R Suckow, R. F. Suckow, R. Suckow, R.F. Suckow, RAYMOND F. SUCKOW, Raymond F Suckow, Raymond F. Suckow, Raymond Suckow, Raymond F. Suckow

103

Publications

3.5K

Citations

H-Index

Concepts

All Affiliations

New York State Psychiatric Institute Nathan Kline Institute for Psychiatric Research New York Psychoanalytic Society and Institute Columbia University Yale University

About

Raymond F. Suckow is an author at New York State Psychiatric Institute specializing in medicine, pharmacology, and social sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	42	2.4K
2	Social Sciences	17	19	1.4K
3	Health Sciences	2	2	113
4	Allergy	2	2	33
5	Engineering	1	1	20

Raymond F. Suckow

Publications

3.4K

Citations

H-Index

Page 1

	Year	Citations
High dose D-serine in the treatment of schizophrenia Joshua T. Kantrowitz, Anil K. Malhotra, Barbara A. Cornblatt, Schizophrenia Research PsychiatryPsychotic DisorderMedicinePsychopharmacologySchizophrenia	2010	242
Relationship of resting brain hyperconnectivity and schizophrenia-like symptoms produced by the NMDA receptor antagonist ketamine in humans Naomi Driesen, Gregory McCarthy, Zubin Bhagwagar, Molecular Psychiatry NeuropsychologyPsychiatryNeurophysiologyBrain HyperconnectivityPsychotropic Medication	2013	231
Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans John Krystal, Laurence P. Karper, Alexandre Bennett, Psychopharmacology MedicinePhysiologyAnesthetic MechanismAnesthesia PracticeNeuropharmacology	1998	185
The Impact of NMDA Receptor Blockade on Human Working Memory-Related Prefrontal Function and Connectivity Naomi Driesen, Gregory McCarthy, Zubin Bhagwagar, Neuropsychopharmacology NeuropsychologyNeurological FunctioningPsychiatryBrain FunctionMedicine	2013	153
A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder Matthew S. Milak, Carol J. Proper, Stephanie Mulhern, Molecular Psychiatry PsychiatryMedicinePsychotropic MedicationNeurotransmitterPsychopharmacology	2015	138
Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to meta-chloro-phenylpiperazine in obsessive-compulsive disorder Eric Hollander, Concetta DeCaria, Robert Gully, Psychiatry Research PsychiatryBehavioral NeuroscienceAddictionChronic Fluoxetine TreatmentBehavioral Pharmacology	1991	120
Expression of Aspartoacylase Activity in Cultured Rat Macroglial Cells Is Limited to Oligodendrocytes Morris H. Baslow, Raymond F. Suckow, Victor S. Sapirstein, Journal of Molecular Neuroscience InflammationMolecular NeuroscienceCell SignalingNeural Stem CellNeuroprotection	1999	100
NMDA antagonist effects on striatal dopamine release: Positron emission tomography studies in humans Lawrence S. Kegeles, Diana Martínez, Lisa D. Kochan, Synapse	2001	92
Effects ofm-chlorophenylpiperazine in normal subjects: a dose-response study René S. Kahn, Scott Wetzler, Gregory M. Asnis, Psychopharmacology MedicineClinical PharmacologyToxicologyPharmacotherapyPharmacology	1990	91
Sex-Specific Effects of Chronic Fluoxetine Treatment on Neuroplasticity and Pharmacokinetics in Mice Georgia E. Hodes, Tiffany E. Hill‐Smith, Raymond F. Suckow, Journal of Pharmacology and Experimental Therapeutics	2009	88

Page 1